Kenvue urges US FDA to reject request for Tylenol’s autism warning
NegativeFinancial Markets

Kenvue is urging the US FDA to reject a request for a warning label on Tylenol regarding autism risks. This matter is significant as it touches on public health concerns and the ongoing debate about the safety of common medications. The outcome could influence consumer trust and regulatory practices surrounding over-the-counter drugs.
— Curated by the World Pulse Now AI Editorial System